Anindhya Sundar Das

Dr. Anindhya Sundar Das

orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2017 in Biochemistry and Biophysics Reports
Verified
Journal Article
Open access
ABAnandita Basu
Anandita Basu
Anindhya Sundar DasAnindhya Sundar Das
Anindhya Sundar Das
MSManoj Sharma
Manoj Sharma
MPManash Pratim Pathak
Manash Pratim Pathak
PCPronobesh Chattopadhyay
Pronobesh Chattopadhyay
RMRupak Mukhopadhyay
Rupak Mukhopadhyay
Cycloxygenase-2 (COX-2) is the inducible isoform of cycloxygenase enzyme family that catalyzes synthesis of inflammatory mediators, prostanoids and prostaglandins, and therefore, can be targeted by anti-inflammatory drugs. Here, we showed a plant polyphenol, kaempferol, attenuated IL-6-induced COX-2 expression in human monocytic THP-1 cells suggesting its beneficial role in chronic inflammation. Kaempferol deactivated and prevented nuclear localization of two major transcription factors STAT3 and NF-κB, mutually responsible for COX-2 induction in response to IL-6. Moreover, STAT3 and NF-κB were simultaneously deactivated by kaempferol in acute inflammation, as shown by carrageenan-induced mouse paw edema model. The concomitant reduction in COX-2 expression in paw tissues suggested kaempferol's role in mitigation of inflammation by targeting STAT3 and NF-κB.

1 July 2016 in Journal of Cardiovascular Pharmacology
Verified
Journal Article
Closed access
ABAnandita Basu
Anandita Basu
Anindhya Sundar DasAnindhya Sundar Das
Anindhya Sundar Das
MMMunmi Majumder
Munmi Majumder
RMRupak Mukhopadhyay
Rupak Mukhopadhyay
Cardiovascular diseases (CVDs) are the commonest cause of global mortality and morbidity. Atherosclerosis, the fundamental pathological manifestation of CVDs, is a complex process and is poorly managed both in terms of preventive and therapeutic intervention. Aberrant lipid metabolism and chronic inflammation play critical roles in the development of atherosclerosis. These processes can be targeted for effective management of the disease. Although managing lipid metabolism is in the forefront of current therapeutic approaches, controlling inflammation may also prove to be crucial for an efficient treatment regimen of the disease. Flavonoids, the plant-derived polyphenols, are known for their antiinflammatory properties. This review discusses the possible antiatherogenic role of 3 flavonoids, namely, chrysin, quercetin, and luteolin primarily known for their antiinflammatory properties.

1 August 2018 in Biochimie
Verified
Journal Article
Closed access
DBDipanjan Banerjee
Dipanjan Banerjee
ASArchana Sinha
Archana Sinha
SSSudeshna Saikia
Sudeshna Saikia
BGBhaskarjyoti Gogoi
Bhaskarjyoti Gogoi
ARArvind K. Rathore
Arvind K. Rathore
SDSuman Dasgupta
Suman Dasgupta

1 July 2024 in Molecular and Cellular Biochemistry
Verified
Journal Article
Closed access
PDF file
Anindhya Sundar DasAnindhya Sundar Das
Anindhya Sundar Das
ABAnandita Basu
Anandita Basu
RMRupak Mukhopadhyay
Rupak Mukhopadhyay

30 August 2019 in Biochemical Journal
Verified
Journal Article
Closed access
PDF file
SCSaynaz A. Choudhary
Saynaz A. Choudhary
NBNikita Bora
Nikita Bora
DBDipanjan Banerjee
Dipanjan Banerjee
LALeena Arora
Leena Arora
Anindhya Sundar DasAnindhya Sundar Das
Anindhya Sundar Das
SDSuman Dasgupta
Suman Dasgupta
Saturated free fatty acid-induced adipocyte inflammation plays a pivotal role in implementing insulin resistance and type 2 diabetes. Recent reports suggest A2A adenosine receptor (A2AAR) could be an attractive choice to counteract adipocyte inflammation and insulin resistance. Thus, an effective A2AAR agonist devoid of any toxicity is highly appealing. Here, we report that indirubin-3′-monoxime (I3M), a derivative of the bisindole alkaloid indirubin, efficiently binds and activates A2AAR which leads to the attenuation of lipid-induced adipocyte inflammation and insulin resistance. Using a combination of in silico virtual screening of potential anti-diabetic candidates and in vitro study on insulin-resistant model of 3T3-L1 adipocytes, we determined I3M through A2AAR activation markedly prevents lipid-induced impairment of the insulin signaling pathway in adipocytes without any toxic effects. While I3M restrains lipid-induced adipocyte inflammation by inhibiting NF-κB dependent pro-inflammatory cytokines expression, it also augments cAMP-mediated CREB activation and anti-inflammatory state in adipocytes. However, these attributes were compromised when cells were pretreated with the A2AAR antagonist, SCH 58261 or siRNA mediated knockdown of A2AAR. I3M, therefore, could be a valuable option to intervene adipocyte inflammation and thus showing promise for the management of insulin resistance and type 2 diabetes.

8 May 2020 in The FEBS Journal
Verified
Journal Article
Open access
PDF file
Anindhya Sundar DasAnindhya Sundar Das
Anindhya Sundar Das
ABAnandita Basu
Anandita Basu
RKRavi Kumar
Ravi Kumar
PBPallab Kumar Borah
Pallab Kumar Borah
SBSubhojit Bakshi
Subhojit Bakshi
RMRupak Mukhopadhyay
Rupak Mukhopadhyay
Monocyte infiltration to the site of pathogenic invasion is critical for inflammatory response and host defence. However, this process demands precise regulation as uncontrolled migration of monocytes to the site delays resolution of inflammation and ultimately promotes chronic inflammation. C‐C motif chemokine ligand 2 (CCL2) plays a key role in monocyte migration, and hence, its expression should be tightly regulated. Here, we report a post‐transcriptional regulation of CCL2 involving the large ribosomal subunit protein L22 (RPL22) in LPS‐activated, differentiated THP‐1 cells. Early events following LPS treatment include transcriptional upregulation of RPL22 and its nuclear accumulation. The protein binds to the first 20 nt sequence of the 5′UTR of ccl2 mRNA. Simultaneous nuclear translocation of up‐frameshift‐1 protein and its interaction with RPL22 results in cytoplasmic degradation of the ccl2 mRNA at a later stage. Removal of RPL22 from cells results in increased expression of CCL2 in response to LPS causing disproportionate migration of monocytes. We propose that post‐transcriptional regulation of CCL2 by RPL22 fine‐tunes monocyte infiltration during a pathogenic insult and maintains homeostasis of the immune response critical to resolution of inflammation.Databases: Microarray data are available in NCBI GEO database (Accession No GSE126525).